CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase II Study of Azacitidine and Entinostat (SNDX-275) in Patients With Advanced Breast Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01349959
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:52.003693+00:00
- Published At
- 2016-03-17T00:00:00+00:00
- Record Updated At
- 2025-04-27
- Results Posted At
- 2016-03-17
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Male Breast Carcinoma", "Recurrent Breast Carcinoma", "Stage IIIC Breast Cancer AJCC v7", "Stage IV Breast Cancer AJCC v6 and v7", "Triple-Negative Breast Carcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-27"- protocolSection.identificationModule.nctId
"NCT01349959"- protocolSection.identificationModule.officialTitle
"Phase II Study of Azacitidine and Entinostat (SNDX-275) in Patients With Advanced Breast Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2016-03-17"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.